G D Pharmavale Limited

POWER SEARCH PRICING

SOLUTIONS

g d pharmavale limited Company Information

Company Number

05678259

Next Accounts

Dec 2025

Directors

Gulraj Dhillon

Shareholders

gulraj dhillon

harjinder kaur dhillon

Group Structure

View All

Industry

Other human health activities

Registered Address

2 cobden mews, 90 the broadway, wimbledon, london, SW19 1RH

Website

g d pharmavale limited Estimated Valuation

£1.5m

Pomanda estimates the enterprise value of G D PHARMAVALE LIMITED at £1.5m based on Net Assets of £622.6k and 2.35x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

G D Pharmavale Limited is a live company located in london, SW19 1RH with a Companies House number of 05678259. It operates in the other human health activities sector, SIC Code 86900. Founded in January 2006, it's largest shareholder is gulraj dhillon with a 99% stake. G D Pharmavale Limited is a established, small sized company, Pomanda has estimated its turnover at £2.9m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded G D Pharmavale Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

4 Strong

1 Regular

5 Weak

Size

annual sales of £2.9m, make it larger than the average company (£728.4k)

Growth

3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (7.2%)

EXPORT

G D Pharmavale Limited's latest turnover from March 2024 is estimated at £2.9 million and the company has net assets of £622.6 thousand. According to their latest financial statements, G D Pharmavale Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	2,918,966	2,368,944	2,036,180	2,158,234	2,026,961	3,765,100	3,251,285	3,119,366	676,831	680,630	571,986	518,712	325,490	154,436	113,698
Other Income Or Grants
Cost Of Sales	2,269,026	1,861,520	1,619,710	1,742,402	1,594,655	2,970,407	2,523,871	2,361,363	521,798	524,310	436,984	390,924	234,609	109,079	82,856
Gross Profit	649,940	507,424	416,470	415,832	432,306	794,694	727,414	758,003	155,033	156,320	135,002	127,789	90,882	45,356	30,843
Admin Expenses	529,724	413,578	400,597	399,027	433,474	711,782	729,985	708,493	107,915	123,030	94,509	72,836	8,193	20,537	-112,042
Operating Profit	120,216	93,846	15,873	16,805	-1,168	82,912	-2,571	49,510	47,118	33,290	40,493	54,953	82,689	24,819	142,885
Interest Payable
Interest Receivable								612	2,306	2,006	1,764	1,514	1,088	749	336
Pre-Tax Profit	120,216	93,846	15,873	16,805	-1,168	82,912	-2,571	50,123	49,424	35,296	42,257	56,467	83,777	25,568	143,221
Tax	-30,054	-17,831	-3,016	-3,193		-15,753		-10,024	-9,885	-7,412	-9,719	-13,552	-21,782	-7,159	-40,102
Profit After Tax	90,162	76,015	12,857	13,612	-1,168	67,159	-2,571	40,098	39,539	27,884	32,538	42,915	61,995	18,409	103,119
Dividends Paid
Retained Profit	90,162	76,015	12,857	13,612	-1,168	67,159	-2,571	40,098	39,539	27,884	32,538	42,915	61,995	18,409	103,119
Employee Costs	26,482	25,094	23,918	23,186	22,719	1,225,044	1,074,806	984,789	232,731	240,299	216,823	215,342	127,929	62,833	40,892
Number Of Employees	1	1	1	1	1	55	50	46	11	11	10	10	6	3	2
EBITDA*	120,216	93,846	15,873	16,805	-1,168	82,912	-2,571	49,510	47,256	33,458	40,698	55,205	82,999	25,075	143,321

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	8,751	8,883	9,038	9,221	8,319	8,352	8,427	8,537	631	769	937	1,142	1,394	1,704	1,960
Intangible Assets									8,000	8,000	8,000	8,000	8,000	8,000	8,000
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets	8,751	8,883	9,038	9,221	8,319	8,352	8,427	8,537	8,631	8,769	8,937	9,142	9,394	9,704	9,960
Stock & work in progress
Trade Debtors	1,003,476	870,002	747,683	723,168	699,421	680,874	579,612	561,324
Group Debtors
Misc Debtors
Cash									489,646	432,638	369,755	335,994	269,571	165,458	134,208
misc current assets
total current assets	1,003,476	870,002	747,683	723,168	699,421	680,874	579,612	561,324	489,646	432,638	369,755	335,994	269,571	165,458	134,208
total assets	1,012,227	878,885	756,721	732,389	707,740	689,226	588,039	569,861	498,277	441,407	378,692	345,136	278,965	175,162	144,168
Bank overdraft
Bank loan
Trade Creditors	389,664	346,484	300,335	288,860	277,823	258,141	224,113	203,364	171,776	154,445	119,614	118,596	95,340	53,532	40,947
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities	389,664	346,484	300,335	288,860	277,823	258,141	224,113	203,364	171,776	154,445	119,614	118,596	95,340	53,532	40,947
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities	389,664	346,484	300,335	288,860	277,823	258,141	224,113	203,364	171,776	154,445	119,614	118,596	95,340	53,532	40,947
net assets	622,563	532,401	456,386	443,529	429,917	431,085	363,926	366,497	326,501	286,962	259,078	226,540	183,625	121,630	103,221
total shareholders funds	622,563	532,401	456,386	443,529	429,917	431,085	363,926	366,497	326,501	286,962	259,078	226,540	183,625	121,630	103,221

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	120,216	93,846	15,873	16,805	-1,168	82,912	-2,571	49,510	47,118	33,290	40,493	54,953	82,689	24,819	142,885
Depreciation									138	168	205	252	310	256	436
Amortisation
Tax	-30,054	-17,831	-3,016	-3,193		-15,753		-10,024	-9,885	-7,412	-9,719	-13,552	-21,782	-7,159	-40,102
Stock
Debtors	133,474	122,319	24,515	23,747	18,547	101,262	18,288	561,324
Creditors	43,180	46,149	11,475	11,037	19,682	34,028	20,749	31,588	17,331	34,831	1,018	23,256	41,808	12,585	40,947
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations	-132	-155	-183	902	-33	-75	-110	-490,250	54,702	60,877	31,997	64,909	103,025	30,501	144,166
Investing Activities
capital expenditure	132	155	183	-902	33	75	110	94							-10,396
Change in Investments
cash flow from investments	132	155	183	-902	33	75	110	94							-10,396
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue								-102							102
interest								612	2,306	2,006	1,764	1,514	1,088	749	336
cash flow from financing								510	2,306	2,006	1,764	1,514	1,088	749	438
cash and cash equivalents
cash								-489,646	57,008	62,883	33,761	66,423	104,113	31,250	134,208
overdraft
change in cash								-489,646	57,008	62,883	33,761	66,423	104,113	31,250	134,208

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for g d pharmavale limited. Get real-time insights into g d pharmavale limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for g d pharmavale limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in SW19 area or any other competitors across 12 key performance metrics.

G D PHARMAVALE LIMITED group structure

G D Pharmavale Limited has no subsidiary companies.

Ultimate parent company

G D PHARMAVALE LIMITED

05678259

G D PHARMAVALE LIMITED Shareholders

gulraj dhillon	99.02%
harjinder kaur dhillon	0.98%

G D Pharmavale Limited currently has 1 director, Mr Gulraj Dhillon serving since Jan 2006.

officer	country	age	start	end	role
Mr Gulraj Dhillon	England	51 years	Jan 2006	-	Director

P&L

March 2024

turnover

2.9m

+23%

operating profit

120.2k

gross margin

22.3%

+3.95%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

622.6k

+0.17%

total assets

+0.15%

cash

net assets

Total assets minus all liabilities

Similar Companies

change healthcare uk holdings limited

2.5

magen david adom uk

anglia d n a services ltd

the deborah ubee trust ltd

crook log chemisal limited

4.5

company number

05678259

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

January 2006

ultimate parent company

None

previous names

N/A

address

2 cobden mews, 90 the broadway, wimbledon, london, SW19 1RH

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to g d pharmavale limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for G D PHARMAVALE LIMITED. This can take several minutes, an email will notify you when this has completed.

g d pharmavale limited Company Information

g d pharmavale limited Estimated Valuation

g d pharmavale limited Estimated Valuation

g d pharmavale limited Estimated Valuation

G D Pharmavale Limited Overview

G D Pharmavale Limited Health Check

G D PHARMAVALE LIMITED financials

g d pharmavale limited Credit Report and Business Information

G D Pharmavale Limited Competitor Analysis

g d pharmavale limited Ownership

g d pharmavale limited directors

g d pharmavale limited company details

g d pharmavale limited Charges & Mortgages

g d pharmavale limited Capital Raised & Share Issues BETA

g d pharmavale limited Companies House Filings - See Documents